Saxenda (liraglutide) is a brand-name drug prescribed for weight management in adults and some children. Saxenda comes as an injection pen that’s typically used once per day. Your doctor will ...

Saxenda (liraglutide) is a prescription-only injectable medication in the same class as Ozempic (semaglutide). However, unlike Ozempic, Saxenda is approved by the Food and Drug Administration (FDA) ...

Saxenda (liraglutide) is a prescription drug used to help with weight loss and weight management in adults and certain children. This drug can interact with other medications and some supplements. For ...

A new, injectable weight-loss drug has been approved by the U.S. Food and Drug Administration. The agency on Tuesday approved Saxenda (liraglutide) for adults who are obese or for those who are ...

Saxenda (liraglutide) and Wegovy (semaglutide) are brand-name injections. They’re both prescribed for weight loss and long-term weight management. Saxenda is used daily, while Wegovy is used weekly.

Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk’s injected Saxenda (liraglutide). The compound, ...

The GLP-1 receptor agonist, which was first approved for adults in December 2014, is now a treatment option for adolescents with obesity ages 12-17 as adjunct to diet and exercise. More specifically, ...

Saxenda Approved for Weight Management The FDA has approved Saxenda (liraglutide [rDNA origin]) injection for chronic weight management. Saxenda is the first glucagon-like peptide-1 (GLP-1) receptor ...

The FDA has approved Saxenda® (liraglutide; Novo Nordisk) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in patients aged 12 years and older with ...

Novo Nordisk’s obesity drug Saxenda, which shares the ingredient liraglutide with the company's diabetes treatment Victoza, has been shown to reduce appetite. The drug is an analog of naturally ...

THE latest weapon in the battle of the bulge is a weight control injection that helps people lose up to eight per cent of their body weight. The nation’s medicines watchdog has approved a new drug ...

Weight loss prescriptions Wegovy, Rybelsus and Saxenda—along with Ozempic—are the “single biggest driver” of employer health costs, adding 1% to the total premium expense for 2025, new data from the ...